Kufa University Obtains Patent
230
20-04-2025

University of Kufa obtained a patent on the SRA 737 Checkpointkinase1 inhibitor as a new targeted therapy for non-small cell lung cancer and colorectal cancer cells.

Related titles

Communicate With the Ministry

Contact us for any inquiries about the services provided by the Ministry of Higher Education and Scientific Research